779 top medical experts on Thrombotic Microangiopathies across 29 countries and 35 U.S. states, including 725 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Thrombotic Microangiopathies: Diseases that result in thrombosis in microvasculature. The two most prominent diseases are purpura, thrombotic thrombocytopenic; and hemolytic-uremic syndrome. Multiple etiological factors include vascular endothelial cell damage due to shiga toxin; factor H deficiency; and aberrant VON willebrand factor formation.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Thrombocytopenia (3,871) and Narrower Categories: Hemolytic-Uremic Syndrome (1,358), Thrombocytopenic Purpura (453).
- Clinical Trials : at least 26 including 2 Active, 5 Completed, 9 Recruiting
- Davies, Stella M Pediatric Hematology-OncologyDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.Subjects: Hematopoietic Stem Cell Transplantation; Graft vs Host Disease; Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Complement System ProteinsCategories: Adverse Effects; Etiology; Pathology; Diagnosis; Therapeutic Use; Immunology
- Laskin, Benjamin L Pediatric NephrologyDivision of Nephrology, Department of Pediatrics, Childrens Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Top HospitalSubjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Complement System Proteins; Graft vs Host DiseaseCategories: Adverse Effects; Etiology; Diagnosis; Therapeutic Use; Drug Therapy; Genetics
- Jodele, Sonata Pediatric Hematology-OncologyDepartment of Pediatrics, University of Cincinnati College of Medicine.Disclosed payments in 2021 from 9 biomedical companies, totalling $48,500, including $24,105 from Omeros CorporationSubjects: Hematopoietic Stem Cell Transplantation; Graft vs Host Disease; Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Complement System ProteinsCategories: Adverse Effects; Pathology; Etiology; Diagnosis; Therapeutic Use; Immunology
- Dandoy, Christopher E Pediatric Hematology-OncologyDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.Subjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Graft vs Host Disease; Complement Inactivating Agents; Pericardial EffusionCategories: Pathology; Adverse Effects; Etiology; Diagnosis; Therapeutic Use; Drug Therapy
- Cataland, Spero R HematologyDivision of Hematology, The Ohio State University, Columbus, OH. Top HospitalMedical school: Ohio State University College of Medicine (MD, 1994)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 82.3/100Disclosed payments in 2021 from 12 biomedical companies, totalling $34,325.46, including $19,900 from Takeda Pharmaceuticals U.S.A., Inc.Subjects: Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Hematopoietic Stem Cell Transplantation; Purpura, Thrombotic Thrombocytopenic; ADAM ProteinsCategories: Diagnosis; Blood; Therapy; Adverse Effects; Drug Therapy; Etiology
- Chima, Ranjit S Pediatric Critical Care MedicineDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.Subjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Graft vs Host Disease; Complement Inactivating Agents; Complement System ProteinsCategories: Adverse Effects; Etiology; Pathology; Therapeutic Use; Diagnosis; Drug Therapy
- Jhaveri, Kenar D NephrologyDivision of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, NY.Disclosed payments in 2021 from 3 biomedical companies, totalling $5,140, including $2,500 from Travere Therapeutics, Inc.Subjects: Hematopoietic Stem Cell Transplantation; COVID-19; Acute Kidney Injury; Betacoronavirus; Coronavirus InfectionsCategories: Etiology; Metabolism; Complications; Adverse Effects; Methods; Pathology
- Myers, Kasiani C Pediatric Hematology-OncologyDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.Subjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Graft vs Host Disease; Complement Inactivating Agents; Abdominal PainCategories: Pathology; Adverse Effects; Diagnosis; Therapeutic Use; Etiology; Drug Therapy
- Nester, Carla M Pediatric NephrologyStead Family Department of Pediatrics and Department of Internal Medicine, University of Iowa, Iowa City, IA; and. Top HospitalDisclosed payments in 2021 from 3 biomedical companies, totalling $5,000, including $4,850 from Novartis Pharmaceuticals CorporationSubjects: Kidney Diseases; Kidney Glomerulus; Pregnancy Complications, Hematologic; QuinineCategories: Diagnosis; Genetics; Adverse Effects; Complications
- Bendapudi, Pavan K Hematology & OncologyHarvard Medical School, Boston, Massachusetts. Top HospitalDisclosed payments in 2021 from 2 biomedical companies, totalling $3,310, including $2,760 from Takeda Pharmaceuticals U.S.A., Inc.Subjects: ADAMTS13 Protein; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; ADAM Proteins; Outcome Assessment, Health CareCategories: Deficiency; Methods; Therapy; Diagnosis; Mortality; Pathology
- Glezerman, Ilya G NephrologyRenal Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.Medical school: Albany Medical College of Union University (MD, 1998)Medicare AcceptedSubjects: Hematopoietic Stem Cell Transplantation; Acute Kidney Injury; Antibodies, Monoclonal; Antineoplastic Agents; HypertensionCategories: Adverse Effects; Etiology; Pathology; Antagonists & Inhibitors; Complications; Drug Therapy
- Wanchoo, Rimda NephrologyDivision of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, New York, USA.Subjects: Betacoronavirus; COVID-19; Coronavirus Infections; Graft vs Host Disease; Hematopoietic Stem Cell TransplantationCategories: Etiology; Complications; Adverse Effects; Pathology
- Makar, Robert S Anatomic Pathology & Clinical PathologyHarvard Medical School, Boston, Massachusetts. Top HospitalMedical school: University of Texas Southwestern Medical School at Dallas (MD, 2000)Medicare AcceptedSubjects: ADAMTS13 Protein; Plasma Exchange; ADAM Proteins; Outcome Assessment, Health Care; Purpura, Thrombotic ThrombocytopenicCategories: Deficiency; Methods; Therapy; Diagnosis; Mortality; Pathology
- Warren, Mikako Pediatric PathologyDivision of Pathology, Childrens Hospital of Los Angeles, Los Angeles, CA; and.Subjects: Hematopoietic Stem Cell Transplantation; Abdominal Pain; Antibodies, Monoclonal, Humanized; Colitis, Ischemic; Complement Inactivating AgentsCategories: Pathology; Adverse Effects; Diagnosis; Therapeutic Use; Drug Therapy; Etiology
- George, James N Hematology & OncologyDepartment of Internal Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.Subjects: Quinine; Anemia, Hemolytic; Purpura, Thrombotic Thrombocytopenic; Registries; ThrombocytopeniaCategories: Chemically Induced; Adverse Effects; Diagnosis; Complications; Genetics; Surgery
- Brodsky, Robert Alan HematologyDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Top HospitalPhysician Highly PublishedMedical school: Hahnemann University College of Medicine (MD, 1989)Medicare AcceptedDisclosed payments in 2021 from 5 biomedical companies, totalling $6,256.13, including $6,256.13 from Alexion Pharmaceuticals, Inc.Subjects: Hematopoietic Stem Cell Transplantation; Postoperative Complications; ADAMTS13 Protein; Anemia, Hemolytic; Atypical Hemolytic Uremic SyndromeCategories: Blood; Genetics; Immunology; Metabolism; Diagnosis; Pathology
- Vasu, Sumithira HematologyDivision of Hematology, The Ohio State University, Columbus, OH, USA. . Top HospitalPhysicianDisclosed payments from biomedical company (Alexion Pharmaceuticals, Inc.) in 2021 for $1,250Subjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Endothelium; Graft vs Host Disease; Transplantation ConditioningCategories: Adverse Effects; Etiology; Diagnosis; Drug Therapy; Physiopathology; Therapeutic Use
- Hirsch, Russel Pediatric CardiologyDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.Disclosed payments in 2021 from 4 biomedical companies, totalling $364.4, including $166.55 from Abbott LaboratoriesSubjects: Hematopoietic Stem Cell Transplantation; Antibodies, Monoclonal, Humanized; Pericardial Effusion; Complement Inactivating Agents; Complement System ProteinsCategories: Adverse Effects; Etiology; Pathology; Therapeutic Use; Drug Therapy; Immunology
- Satoskar, Anjali A Anatomic Pathology & Clinical PathologyDepartment of Pathology, The Ohio State University, Columbus, Ohio, USA. Top HospitalPhysician Highly PublishedMedical school: Other (MD, 1994)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 82.3/100Disclosed payments from biomedical company (Alexion Pharmaceuticals, Inc.) in 2021 for $121.15Subjects: Graft Rejection; Antibodies, Monoclonal, Humanized; Kidney Transplantation; Arterioles; Complement Inactivating AgentsCategories: Immunology; Pathology; Adverse Effects; Drug Therapy; Pharmacology; Therapy
- Sethi, Sanjeev Anatomic Pathology & Clinical PathologyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: . Top HospitalPhysician Case ReportsMedical school: Other (MD, 1985)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100Disclosed payments from biomedical company (Novartis Pharmaceuticals Corporation) in 2021 for $10,000Subjects: Antimetabolites, Antineoplastic; Complementary Therapies; Deoxycytidine; Evidence-Based Medicine; Granulomatosis with PolyangiitisCategories: Epidemiology; Standards; Drug Therapy; Adverse Effects; Analogs & Derivatives; Chemically Induced
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.